24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Chemotherapy Industry, February 2015 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, cancer, therapeutics, colorectal cancer, medical equipment, breast cancer, cancer drug, cancer therapeutics, drug, prostate cancer, peripheral neuropathy, radiation therapy, alopecia, biomarker.


 
1-10 of 83 reports for Chemotherapy

Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

  • $ 5 000
  • Industry report
  • January 2015
  • by Frost & Sullivan

Executive Summary •The estimated market size for lung cancer therapeutics in 2014 was $ x billion. •There is increasing competition in this market, especially amongst the large pharmaceutical (pharma) ...

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015', provides an overview of the Chemotherapy ...

Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

TOWA PHARMACEUTICAL CO., LTD. (Symbol:4553) SWOT Analysis, Strategy, Revenues and Profits

TOWA PHARMACEUTICAL CO., LTD. (Symbol:4553) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Cleveland BioLabs, Inc. (Symbol:CBLI) SWOT Analysis, Strategy, Revenues and Profits

Cleveland BioLabs, Inc. (Symbol:CBLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

KPJ Healthcare Berhad (Symbol:KPJ) SWOT Analysis, Strategy, Revenues and Profits

KPJ Healthcare Berhad (Symbol:KPJ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

PledPharma AB (PLED) - Financial and Strategic SWOT Analysis Review

PledPharma AB (PLED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary PledPharma AB (PledPharma) is a pharmaceutical company. The company develops pharmaceutical products for oncology market. Its products under clinical development include PP-095, and PP-099. PledPharma's ...

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Tesaro, Inc. (Tesaro) is an oncology-focused biopharmaceutical company. It focuses on acquiring, in-licensing, developing and commercializing oncology therapeutics and supportive care products. ...

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

  • $ 2 500
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenito ...

About 2 800 reports for Chemotherapy

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    72 pages
  • Cancer  

  • United States  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.